Compare Bio Protocol (BIO) vs xMoney (UTK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs xMoney — how do they compare? Bio Protocol trades at Rp516.76 (market cap Rp1,15T, Rp264,79M 24h volume), while xMoney trades at Rp136.05 (market cap Rp98,35M, Rp327,35M 24h volume). The key difference: Bio Protocol is far larger — about 11692.9× xMoney's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 704,1M / 1B UTK (71%) for xMoney. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and xMoney for 47 Days on average.
| BIO | UTK | |
|---|---|---|
Market Cap | Rp1,15T | Rp98,35M |
Volume (24h) | Rp264,79M | Rp327,35M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 704,1M / 1B UTK (71%) |
Typical Hold Time | 16 Days | 47 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
UTK (xMoney) is a micro-cap cryptocurrency with a market cap of Rp98.35M and 71% of its 1M max supply in circulation. Current price data is unavailable, but the token shows a moderate hold time of 47 days. No recent protocol updates or major ecosystem developments have been reported, indicating limited recent network activity.
The outlook remains speculative due to low liquidity and market cap. Key opportunities include potential growth from increased adoption, but major risks involve extreme volatility, low trading volume, and regulatory uncertainty. Investors should exercise caution given the asset's niche status and limited market presence.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About xMoney
xMoney (formerly known as Utrust) was designed to provide a solution to the problems resulting in low usability of cryptocurrency as means of payment, particularly the underdeveloped transactional security of payment platforms and relatively high fees. The main goal of the platform is to build a system that will enable fast and seamless crypto transactions at lower fees, therefore allowing merchants to reach a large audience of crypto holders. This platform allows buyers to make secure purchases while also offering an option for refunds and protecting sellers from the high volatility of the crypto market.
Read more on UTK →
